Joshua Barocas, MD is an Assistant Professor of Medicine at the Boston University School of Medicine and Infectious Diseases physician at Boston Medical Center. . He received his medical degree from the George Washington University School of Medicine and Public Health. He completed his Internal Medicine residency and was subsequently Chief Resident at the University of Wisconsin Hospitals and Clinics. Dr. Barocas completed a fellowship in Infectious Diseases at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, MA.
He leads an an interdisciplinary research program that is specifically aimed at the goal of improving health outcomes for patients with infectious diseases including HIV and HCV, substance use disorders, and other vulnerable populations. His research, which uses clinical epidemiology, health economics, simulation modeling, and cost-effectiveness, informs clinical-decision making and health policy to answer clinically- and policy-relevant questions. He is engaged in research using these innovative methods to help understand the impact of and improve upon policies that affect people who use drugs infected with or at high risk for HIV and viral hepatitis. His research has been funded by NIDA, NIAID, the Providence/Boston Center for AIDS Research (CFAR), the BU-CTSI, and the MGH Executive Committee on Research Fund for Medical Discovery. He currently serves as Director of the Health Economics and Modeling Core for the Massachusetts HEALing Communities Study, an NIH-funded grant to significantly reduce overdose. He has been the recipient of several research awards including a NIDA Career Development Award (K01), the Charles A. King Trust Research Award, and the prestigious AAMC Herbert W. Nickens Faculty Fellowship Award, which recognizes a junior faculty member who demonstrates leadership potential in addressing inequity in health care. He has published over 30 peer-reviewed articles and editorials, including in leading journals such as NEJM, JAMA Internal Medicine, AJPH, Addiction, Clinical Infectious Diseases, and Annals of Internal Medicine. His work has been widely cited in the media, including the Boston Globe, U.S. News and World Report, and NPR.
- George Washington University School of Medicine, MD
- Washington University in St. Louis, BA
- Published on 9/12/2021
Jawa R, Stein MD, Anderson B, Liebschutz JM, Stewart C, Phillips KT, Barocas JA. Behavioral Risk Factors for HIV Infection in Hospitalized Persons Who Co-use Stimulants and Opioids. AIDS Behav. 2021 Sep 12. PMID: 34510289.
- Published on 9/10/2021
King CA, Englander H, Korthuis PT, Barocas JA, McConnell KJ, Morris CD, Cook R. Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality. PLoS One. 2021; 16(9):e0256793. PMID: 34506517.
- Published on 9/9/2021
Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study. Clin Infect Dis. 2021 Sep 09. PMID: 34499124.
- Published on 7/16/2021
Harris MTH, Young S, Barocas J, Bayoumi AM, Caudarella A, Laurence G, Tomanovich M, Komaromy M. A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto. Public Health Rep. 2021 Sep-Oct; 136(5):532-537. PMID: 34269625.
- Published on 7/1/2021
Barocas JA, Earnest M. The Urgent Public Health Need to Develop "Crisis Standards of Housing": Lessons From the COVID-19 Pandemic. Am J Public Health. 2021 07; 111(7):1207-1209. PMID: 34370530.
- Published on 5/21/2021
Morgan JR, Walley AY, Murphy SM, Chatterjee A, Hadland SE, Barocas J, Linas BP, Assoumou SA. Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort. Drug Alcohol Depend. 2021 08 01; 225:108764. PMID: 34051547.
- Published on 5/20/2021
Epstein RL, Sperring H, Hofman M, Lodi S, White LF, Barocas JA, Bouton TC, Xiao Y, Hsu HE, Miller NS, Linas BP, Marathe JG. Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals? Open Forum Infect Dis. 2021 Jun; 8(6):ofab164. PMID: 34189164.
- Published on 5/1/2021
Dunham K, McDonald J, Yousaf A, Barocas JA, Neill M, Noska A, Flanigan TP. Healthcare Providers' Views on Hepatitis C Testing and Counseling Among Sexual Partners of Hepatitis-C-Infected Persons: An Online Survey. Infect Dis Clin Pract (Baltim Md). 2021 May; 29(3):e151-e153. PMID: 34447237.
- Published on 4/26/2021
Barocas JA. It's Not Them, It's Us: Hepatitis C Reinfection Following Successful Treatment Among People Who Inject Drugs. Clin Infect Dis. 2021 04 26; 72(8):1401-1403. PMID: 32166311.
- Published on 4/6/2021
Hadland SE, Bagley SM, Gai MJ, Earlywine JJ, Schoenberger SF, Morgan JR, Barocas JA. Opioid use disorder and overdose among youth following an initial opioid prescription. Addiction. 2021 10; 116(10):2790-2800. PMID: 33739476.
View 51 more publications: View full profile at BUMC